Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
PharmEste
company
About
PharmEste s.r.l. is a biopharmaceutical company.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- €4.80M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2003
- Operating Status
- Close
PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€4.80M
PharmEste has raised a total of
€4.80M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2011 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2011 | Series B | €4.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
PharmEste is funded by 1 investors.
MPS Venture
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
MPS Venture
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
